Category: Antibodies

Filter By
Categories: Intracellular Functional Antibodies Categories: Isotype Controls Clear all
Sibeprenlimab Sibeprenlimab

Sibeprenlimab

Reference: HY-P99901
€0.00 (tax incl.)
Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody. Sibeprenlimab can inhibit APRIL. Sibeprenlimab can be used for the research of IgA nephropathy (IgAN).
Tengonermin Tengonermin

Tengonermin

Reference: HY-P99565
€0.00 (tax incl.)
Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and...
Tinurilimab Tinurilimab

Tinurilimab

Reference: HY-P99051
€0.00 (tax incl.)
Tinurilimab (Bay 1834942) is an anti-CEACAM6 monoclonal antibody. CEACAM6 is an immune checkpoint regulator suppressing the activity of effector T-cells against tumors.
Ralpancizumab Ralpancizumab

Ralpancizumab

Reference: HY-P99816
€0.00 (tax incl.)
Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke.
Glenzocimab Glenzocimab

Glenzocimab

Reference: HY-P99644
€0.00 (tax incl.)
Glenzocimab (ACT017) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke.
Pepinemab Pepinemab

Pepinemab

Reference: HY-P99407
€0.00 (tax incl.)
Pepinemab (VX 15/2503) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), also known as CD100, which is a regulator of neuronal development and plays a role in a variety of cellular...
Bepranemab Bepranemab

Bepranemab

Reference: HY-P99471
€0.00 (tax incl.)
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research.
Efgivanermin alfa Efgivanermin alfa

Efgivanermin alfa

Reference: HY-P99907
€0.00 (tax incl.)
Efgivanermin alfa is an active peptide. Efgivanermin alfa can be used for various biochemical studies.
Namilumab Namilumab

Namilumab

Reference: HY-P99307
€0.00 (tax incl.)
Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis.
Lirentelimab Lirentelimab

Lirentelimab

Reference: HY-P99371
€0.00 (tax incl.)
Lirentelimab (AK002) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). Lirentelimab induces cell apoptosis of IL-5-activated eosinophils and inhibits IgE-mediated...
Garivulimab Garivulimab

Garivulimab

Reference: HY-P99633
€0.00 (tax incl.)
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity.
Cudarolimab Cudarolimab

Cudarolimab

Reference: HY-P99836
€0.00 (tax incl.)
Cudarolimab (IBI101) is a completely human anti-OX40 (CD134, a co stimulating molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has...
Actoxumab Actoxumab

Actoxumab

Reference: HY-P99277
€0.00 (tax incl.)
Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response,...
Vorsetuzumab Vorsetuzumab

Vorsetuzumab

Reference: HY-P99273
€0.00 (tax incl.)
Vorsetuzumab (Anti-Human CD70 Recombinant Antibody) is a human anti-CD70 antibody. Vorsetuzumab enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma.
Aldafermin Aldafermin

Aldafermin

Reference: HY-P99428
€0.00 (tax incl.)
Aldafermin (NGM282) is an analog of fibroblast growth factor 19. Aldafermin can be used for the research of nonalcoholic steatohepatitis (NASH).
Diridavumab Diridavumab

Diridavumab

Reference: HY-P99853
€0.00 (tax incl.)
Diridavumab is a monoclonal anti-HA stalk antibody. Diridavumab stabilizes the prefusion HA structure and prevents pH-dependent fusion of cellular and viral membranes in endosomes. Diridavumab can be used in research...
Clesrovimab Clesrovimab

Clesrovimab

Reference: HY-P99804
€0.00 (tax incl.)
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection.
Ivuxolimab Ivuxolimab

Ivuxolimab

Reference: HY-P99159
€0.00 (tax incl.)
Ivuxolimab is an OX40 (also known as CD134; TNFRSF4) agonist monoclonal antibody. OX40 is a costimulatory receptor expressed on activated CD4+ and CD8+ T cells. Ivuxolimab shows antitumor activity, with potential...
Nivolumab (anti-PD-1) Nivolumab (anti-PD-1)

Nivolumab (anti-PD-1)

Reference: HY-P9903A
€0.00 (tax incl.)
Nivolumab (anti-PD-1) is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
Xeligekimab Xeligekimab

Xeligekimab

Reference: HY-P99515
€0.00 (tax incl.)
Xeligekimab (GR 1501) is an anti-human interleukin 17A (IL-17A) humanized monoclonal antibody. Xeligekimab inhibits the pro-inflammatory cascade.
Acasunlimab Acasunlimab

Acasunlimab

Reference: HY-P99419
€0.00 (tax incl.)
Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. Acasunlimab enhances T-cell and NK-cell function through conditional 4-1BB stimulation while constitutively blocking the PD-1/PD-L1...
Rovalpituzumab Rovalpituzumab

Rovalpituzumab

Reference: HY-P99043
€0.00 (tax incl.)
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity...
Verpasep caltespen Verpasep caltespen

Verpasep caltespen

Reference: HY-P99522
€0.00 (tax incl.)
Verpasep caltespen (HspE7) is a recombinant fusion protein derived from Mycobacterium bovis Calmette-Guérin heat shock protein 65 (Hsp65), the C-terminal end of which is covalently linked to the E7 protein of HPV16....
Belantamab Belantamab

Belantamab

Reference: HY-P9980
€0.00 (tax incl.)
Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin.
Pertuzumab Pertuzumab

Pertuzumab

Reference: HY-P9912
€0.00 (tax incl.)
Pertuzumab, a humanized IgG1 monoclonal antibody, is a HER2 dimerization inhibitor for the treatment of metastatic HER2-positive breast cancer.
Giloralimab Giloralimab

Giloralimab

Reference: HY-P99640
€0.00 (tax incl.)
Giloralimab (ABBV-927) is a potent antiCD40 agonistic monoclonal antibody. Giloralimab has the potential for the research of cancer.
Alemtuzumab Alemtuzumab

Alemtuzumab

Reference: HY-P9948
€0.00 (tax incl.)
Alemtuzumab (Campath-IH) is a humanized monoclonal antibody against CD52, a glycoprotein expressed on the surface of most lymphoid, and to a lesser extent, myeloid cell types. Alemtuzumab selectively targets the CD52...
Upifitamab Upifitamab

Upifitamab

Reference: HY-P99229
€0.00 (tax incl.)
Upifitamab is an ADC Antibody (a naked antibody of upifitamab rilsodotin), which can be used for antibody-coupled agent (ADC) synthesis. Upifitamab rilsodotin is an ADC targeting NaPi2b and is used in ovarian cancer...
Obinutuzumab Obinutuzumab

Obinutuzumab

Reference: HY-P9910
€0.00 (tax incl.)
Obinutuzumab (GA101) a novel glycoengineered Type II CD20 humanized IgG1 monoclonal antibody in development for non-Hodgkin lymphoma.
Nimacimab Nimacimab

Nimacimab

Reference: HY-P99755
€0.00 (tax incl.)
Nimacimab (RYI-018) is a negative-allosteric modulating monoclonal antibody targeting CB1 receptor. Nimacimab can be used for research of metabolic diseases.
Rontalizumab Rontalizumab

Rontalizumab

Reference: HY-P99267
€0.00 (tax incl.)
Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].
Olinvacimab Olinvacimab

Olinvacimab

Reference: HY-P99768
€0.00 (tax incl.)
Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to KDR with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the...
Budigalimab Budigalimab

Budigalimab

Reference: HY-P99489
€0.00 (tax incl.)
Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function.
Unasnemab Unasnemab

Unasnemab

Reference: HY-P99959
€0.00 (tax incl.)
Unasnemab (MT-3921) is a humanised IgG1 monoclonal antibody that binds to repulsive guidance molecule A (RGMa). Unasnemab improves locomotor function and promotes neuroregeneration and can be used for the research of...
Zimberelimab Zimberelimab

Zimberelimab

Reference: HY-P99109
€0.00 (tax incl.)
Zimberelimab is a fully human IgG4 anti-PD-1 monoclonal antibody with high affinity and selectivity. Zimberelimab shows antitumor activities and can be used for various cancers research including cervical cancer,...
Infliximab Infliximab

Infliximab

Reference: HY-P9970
€0.00 (tax incl.)
Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for...
Lacnotuzumab Lacnotuzumab

Lacnotuzumab

Reference: HY-P99368
€0.00 (tax incl.)
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis.
Laprituximab Laprituximab

Laprituximab

Reference: HY-P99684
€0.00 (tax incl.)
Laprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289.
Ulocuplumab Ulocuplumab

Ulocuplumab

Reference: HY-P99272
€0.00 (tax incl.)
Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic...
Priliximab Priliximab

Priliximab

Reference: HY-P99790
€0.00 (tax incl.)
Priliximab (CEN 000029) is an anti-CD4 humanized monoclonal antibody. Priliximab binds to CD4 on the surface of T cells, resulting in a significant and sustained reduction in circulating CD4+ T cells. Priliximab can...
Mupadolimab Mupadolimab

Mupadolimab

Reference: HY-P99181
€0.00 (tax incl.)
Mupadolimab (CPI-006) is an IgG1κ humanized FcγR binding-deficient anti-CD73 monoclonal antibody (mAb) that activates CD73POS B cells.
Eculizumab Eculizumab

Eculizumab

Reference: HY-P9914
€0.00 (tax incl.)
Eculizumab (Anti-Human C5, Humanized Antibody) is a long-acting humanized monoclonal antibody targeted against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of...
Datopotamab Datopotamab

Datopotamab

Reference: HY-P99843
€0.00 (tax incl.)
Datopotamab (CDP7657) is an antibody targeting to TROP2. Datopotamab can be used to synthesize Datopotamab deruxtecan (HY-141598), TROP2-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan consists of DNA...
Tafasitamab Tafasitamab

Tafasitamab

Reference: HY-P9981
€0.00 (tax incl.)
Tafasitamab (XmAb5574) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigenCD19.
Cetrelimab Cetrelimab

Cetrelimab

Reference: HY-P99499
€0.00 (tax incl.)
Cetrelimab (JNJ 63723283; JNJ 3283) is a humanized IgG4κ mAb targeting PD-1. Cetrelimab binds PD-1 (Kd=1.72 nM, HEK293) to block the interaction of PD-1 with PD-L1 and PD-L2 (IC50s=111.7 ng/mL and 138.6 ng/mL,...
MDX-1342 MDX-1342

MDX-1342

Reference: HY-P99173
€0.00 (tax incl.)
MDX-1342 is a fully human monoclonal antibody (HuMAb) of targeting CD19-membrane receptor. MDX-1342 can specifically bind to human CD19 antigen with high affinity and has antibody-dependent cellular cytotoxicity...
Rivabazumab pegol Rivabazumab pegol

Rivabazumab pegol

Reference: HY-P99954
€0.00 (tax incl.)
Rivabazumab pegol is a PcrV protein antibody that can be used to study the phase II pegylated Fab of chronic Pseudomonas aeruginosa infection.
Ublituximab Ublituximab

Ublituximab

Reference: HY-P99538
€0.00 (tax incl.)
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects.
Ginisortamab Ginisortamab

Ginisortamab

Reference: HY-P99643
€0.00 (tax incl.)
Ginisortamab (UCB6114) is a fully human IgG4P antiGremlin-1 monoclonal antibody. Ginisortamab has the potential for the research of gastrointestinal (GI) tumors.
Nivatrotamab Nivatrotamab

Nivatrotamab

Reference: HY-P99757
€0.00 (tax incl.)
Nivatrotamab (Hu3F8-BsAb) is a humanized anti-GD2/CD3 bispecific antibody. Nivatrotamab is a CD3- and GD2-specific bsAb-based T-cell engager. Nivatrotamab can be used in research of neuroblastoma.

Menu

Settings

Please sign in first.

Sign in